So let me start by saying that this question may seem a bit callous, and that on a personal level I wish everyone suffering from long COVID nothing but good health.
That said there seems to be a growing body of evidence that many people who have had COVID, even those with mild cases, will potentially be more susceptible to other health problems for awhile and conceivably for the rest of their lives. This includes a host of cardiovascular problems as well as neurological and other health issues.
- https://www.nature.com/articles/s41591-022-01689-3
- https://www.nature.com/articles/d41586-022-00503-x
- https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00299-6/fulltext
- https://twitter.com/ahandvanish/status/1502034441010569221?s=20&t=pv_qRMH4TLhp1Yl9qufBTw
So in addition to “long COVID” as many of us have witnessed, there’s this whole other layer of increased likelihood of other illnesses from to early onset dementia to heart disease and strokes.
Based on this I think one can assume that there will be more demand for treatment for primarily cardiovascular health issues in a younger population. Has anyone looked into any companies that work in this area that might see increased demand? Or is this all sort of just lumped into the major healthcare players?
As you can tell I’m fairly ignorant on HC having basically no exposure to it currently.
And to be clear I don’t mean investing in the assumption that the pandemic will continue forever. I mean specifically in the treatment of the thousands of people who will be feeling the long term repercussions of having had Covid, even mild cases.
And I’ll also just say reading about long COVID definitely inspires me to keep masking but I don’t want to open a debate on anything like that. You do you.
Leave a Reply